Clinical study to investigate menopause app

A new 12-week clinical study is to investigate the MENO! App, which has been designed to support symptoms relief for women experiencing menopause. 

One in four women suffer from severe menopause symptoms such as hot flashes, sleep disturbances, and mood changes that significantly impact their quality of life and work, yet treatment options remain limited and often inaccessible.

The decentralised, randomised-controlled clinical study will take place in Germany and study will evaluate the effectiveness of MENO! App, enrolling women aged 40 to 65 experiencing bothersome menopausal symptoms.

Participants will be randomised into two groups, one using the MENO! App and the other receiving standard care. After completion, the control group will also gain access to the app, ensuring all participants benefit from this innovation.

“We invest in innovative digital health solutions that address the individual needs of women at various stages of life,” said Professor Pia Wülfing, chief clinical officer for Sidekick Health Group, which has developed the app, and a licensed OB/GYN.

“Our focus lies in combining technology with medical expertise to improve healthcare outcomes.”

MENO! App is a CE-marked digital therapeutic for menopause, offering evidence-based cognitive behavioural therapy (CBT) specifically designed to reduce symptom burden.

The app provides a non-hormonal, accessible alternative to help women manage their symptoms holistically. The app integrates behavioural interventions with lifestyle support.